A detailed history of Srs Capital Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 5,262 shares of ZTS stock, worth $916,850. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,262
Previous 5,124 2.69%
Holding current value
$916,850
Previous $1.01 Million 11.97%
% of portfolio
0.1%
Previous 0.12%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $22,862 - $27,591
138 Added 2.69%
5,262 $890,000
Q4 2023

Feb 06, 2024

BUY
$151.44 - $200.09 $22,413 - $29,613
148 Added 2.97%
5,124 $1.01 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $471,000 - $543,225
2,818 Added 130.58%
4,976 $865,000
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $3,218 - $3,724
20 Added 0.94%
2,158 $371,000
Q1 2023

May 16, 2023

BUY
$145.48 - $175.02 $30,259 - $36,404
208 Added 10.78%
2,138 $355,000
Q4 2022

Feb 24, 2023

BUY
$131.14 - $157.47 $21,244 - $25,510
162 Added 9.16%
1,930 $282,000
Q3 2022

Nov 03, 2022

BUY
$148.29 - $182.55 $5,486 - $6,754
37 Added 2.14%
1,768 $262,000
Q2 2022

Aug 22, 2022

BUY
$155.97 - $200.09 $5,147 - $6,602
33 Added 1.94%
1,731 $298,000
Q1 2022

May 12, 2022

BUY
$181.39 - $234.03 $1,995 - $2,574
11 Added 0.65%
1,698 $320,000
Q4 2021

Feb 08, 2022

SELL
$193.69 - $247.03 $13,945 - $17,786
-72 Reduced 4.09%
1,687 $412,000
Q3 2021

Nov 05, 2021

SELL
$189.29 - $209.69 $4,921 - $5,451
-26 Reduced 1.46%
1,759 $342,000
Q2 2021

Aug 02, 2021

BUY
$155.9 - $187.99 $7,483 - $9,023
48 Added 2.76%
1,785 $333,000
Q4 2020

Feb 03, 2021

SELL
$157.07 - $174.35 $3,455 - $3,835
-22 Reduced 1.25%
1,737 $287,000
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $8,774 - $10,583
-64 Reduced 3.51%
1,759 $291,000
Q2 2020

Aug 06, 2020

SELL
$111.92 - $142.53 $35,366 - $45,039
-316 Reduced 14.77%
1,823 $250,000
Q1 2020

May 13, 2020

SELL
$92.66 - $144.94 $22,609 - $35,365
-244 Reduced 10.24%
2,139 $252,000
Q4 2019

Feb 07, 2020

BUY
$116.25 - $133.25 $1,511 - $1,732
13 Added 0.55%
2,383 $315,000
Q3 2019

Nov 01, 2019

SELL
$112.57 - $128.43 $26,566 - $30,309
-236 Reduced 9.06%
2,370 $295,000
Q2 2019

Aug 08, 2019

BUY
$97.98 - $114.28 $1,371 - $1,599
14 Added 0.54%
2,606 $296,000
Q4 2018

Feb 06, 2019

SELL
$79.28 - $95.27 $13,160 - $15,814
-166 Reduced 6.02%
2,592 $222,000
Q3 2018

Nov 06, 2018

SELL
$83.5 - $93.23 $12,775 - $14,264
-153 Reduced 5.26%
2,758 $252,000
Q2 2018

Aug 21, 2018

BUY
$79.9 - $89.2 $226,516 - $252,882
2,835 Added 3730.26%
2,911 $248,000
Q1 2018

May 14, 2018

BUY
$71.51 - $84.69 $1,787 - $2,117
25 Added 49.02%
76 $6,000
Q4 2017

Feb 15, 2018

BUY
$63.24 - $72.8 $379 - $436
6 Added 13.33%
51 $3,000
Q3 2017

Nov 15, 2017

BUY
$59.73 - $65.4 $2,687 - $2,943
45
45 $2,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.